前额叶皮层神经变异性反映帕金森病患者的神经灵活性与稳定性
本研究采用功能性近红外光谱(fNIRS)传感器置于前额,比较57名健康对照与149名特发性帕金森病(PD)患者在常规步行和双任务步行(连续减3)时前额叶皮层HbO2信号的变异性。结果显示,健康对照在双任务步行时变异性高于常规步行,而PD患者任务重复时变异性增加、健康对照降低;PD患者常规步行时HbO2变异性高于健康对照,双任务步行时则无差异。
要点
- PD患者常规步行时前额叶HbO2变异性高于健康对照,双任务步行时未见差异。
- 健康对照双任务步行时HbO2变异性高于常规步行,PD患者未见此差异。
- 健康对照任务重复时HbO2变异性降低,PD患者则升高。
核心结论
- 作者认为HbO2变异性增加反映对环境挑战的灵活适应,降低反映表现稳定性,两者在PD中均受限,但需进一步研究。
研究设计与样本
- 共纳入206名参与者,包括57名健康对照(年龄68.9±1.0岁,女性27名)和149名特发性PD患者(年龄69.8±0.6岁,女性50名,病程8.27±5.51年)。
- 参与者完成常规步行和双任务步行(连续减3),前额佩戴fNIRS传感器。
- HbO2变异性通过fNIRS衍生HbO2信号的标准差、范围和平均去趋势时间序列计算,采用混合模型分析比较组间和任务间差异。
主要发现
- 双任务步行时HbO2变异性(标准差、范围、平均去趋势时间序列)高于常规步行(p<0.025),但该差异源于健康对照组内(组×任务交互p<0.007)。
- 任务重复时健康对照变异性降低而PD患者变异性增加(组×步行重复交互p<0.048)。
- 在所有参与者中,常规步行时MDS-UPDRS运动评分与HbO2范围(r=0.142,p=0.050)和HbO2标准差(r=0.173,p=0.018)相关。
关键数值与推荐
- 本研究提供III级证据表明PD患者常规步行时HbO2信号变异性高于健康对照,但双任务步行时无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出这些概念需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Functional near-infrared spectroscopy (fNIRS) studies provide direct evidence of the important role of the prefrontal cortex (PFC) during walking in aging and Parkinson disease (PD). Most studies explored mean hemoglobin (HbO2) levels, while moment-to-moment variability measures have rarely been investigated. Variability measures can inform on flexibility, which is imperative for adaptive function. We hypothesized that patients with PD will show less variability in HbO2 signals during walking compared to healthy controls. METHODS: Two hundred six participants, 57 healthy controls (age 68.9 ± 1.0 years, 27 women) and 149 patients with idiopathic PD (age 69.8 ± 0.6 years, 50 women, disease duration 8.27 ± 5.51 years), performed usual walking and dual-task walking (serial 3 subtractions) with an fNIRS sensor placed on the forehead. HbO2 variability was calculated from the SD, range, and mean detrended time series of fNIRS-derived HbO2 signal evaluated during each walking task. HbO2 variability was compared between groups and between walking tasks with mixed model analyses. RESULTS: Higher variability (SD, range, mean detrended time series) was observed during dual-task walking compared to usual walking (p < 0.025), but this was derived from the differences within the healthy control group (group × task interaction p < 0.007). On the other hand, task repetition demonstrated reduced variability in healthy controls but increased variability in patients with PD (interaction group × walk repetition p < 0.048). The Movement Disorder Society Unified Parkinson's Disease Rating Scale motor score correlated with HbO2 range (r = 0.142, p = 0.050) and HbO2 SD (r = 0.173, p = 0.018) during usual walking among all participants. DISCUSSION: In this study, we suggest a new way to interpret changes in HbO2 variability. We relate increased HbO2 variability to flexible adaptation to environmental challenges and decreased HbO2 variability to the stability of performance. Our results show that both are limited in PD; however, further investigation of these concepts is required. Moreover, HbO2 variability measures are an important aspect of brain function that add new insights into the role of PFC during walking with aging and PD. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov Identifier: NCT01732653. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that patients with PD have more variability within HbO2 signals during usual walking compared to healthy controls but not during dual-task walking.
引用
- Maidan I, Hacham R, Galperin I, et al. Neural Variability in the Prefrontal Cortex as a Reflection of Neural Flexibility and Stability in Patients With Parkinson Disease. Neurology. 2021. PMID: 34906983. doi:10.1212/WNL.0000000000013217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。